edaravone has been researched along with Pre-Eclampsia in 2 studies
Pre-Eclampsia: A complication of PREGNANCY, characterized by a complex of symptoms including maternal HYPERTENSION and PROTEINURIA with or without pathological EDEMA. Symptoms may range between mild and severe. Pre-eclampsia usually occurs after the 20th week of gestation, but may develop before this time in the presence of trophoblastic disease.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Edaravone is a powerful free radical scavenger used for the treatment of ischemia/reperfusion diseases due to its anti-oxidative stress and anti-inflammatory properties." | 8.02 | Effect of edaravone on pregnant mice and their developing fetuses subjected to placental ischemia. ( Abe, K; Atallah, M; Yamashita, T, 2021) |
| "Pretreatment with edaravone significantly inhibited hypoxia-induced oxidative stress formation and sFlt-1 expression in trophoblasts." | 5.40 | Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia. ( Han, L; Liu, XX; Luo, QQ; Yan, T; Zhao, Y; Zheng, YF; Zou, L, 2014) |
| " Edaravone is a powerful free radical scavenger used for the treatment of ischemia/reperfusion diseases due to its anti-oxidative stress and anti-inflammatory properties." | 4.02 | Effect of edaravone on pregnant mice and their developing fetuses subjected to placental ischemia. ( Abe, K; Atallah, M; Yamashita, T, 2021) |
| "Pretreatment with edaravone significantly inhibited hypoxia-induced oxidative stress formation and sFlt-1 expression in trophoblasts." | 1.40 | Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia. ( Han, L; Liu, XX; Luo, QQ; Yan, T; Zhao, Y; Zheng, YF; Zou, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atallah, M | 1 |
| Yamashita, T | 1 |
| Abe, K | 1 |
| Zhao, Y | 1 |
| Zheng, YF | 1 |
| Luo, QQ | 1 |
| Yan, T | 1 |
| Liu, XX | 1 |
| Han, L | 1 |
| Zou, L | 1 |
2 other studies available for edaravone and Pre-Eclampsia
| Article | Year |
|---|---|
Effect of edaravone on pregnant mice and their developing fetuses subjected to placental ischemia.
Topics: Animals; Disease Models, Animal; Edaravone; Female; Ischemia; Male; Mice; Mice, Inbred C57BL; Oxidat | 2021 |
Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
Topics: Antipyrine; Cell Hypoxia; Cell Line; Cobalt; Edaravone; Female; Free Radical Scavengers; Gene Expres | 2014 |